2007
DOI: 10.1002/chir.20503
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a new C2‐symmetric chiral catalyst and its application in the catalytic asymmetric borane reduction of prochiral ketones

Abstract: A new C(2)-symmetric chiral catalyst 3,5-bis[(2S)-(hydroxy-diphenylmethyl)- pyrrolidin-1-ylmethyl]-1,3,4-oxadiazole was successfully synthesized by the reaction of 2,5-dichloromethyl-1,3,4-oxadiazole with (S)-alpha,alpha-diphenyl-2-pyrrolidinemethanol, and applied to the catalytic asymmetric reduction of prochiral ketones with borane. When the catalyst loading was 1 mol %, enantiomeric excesses of up to 86.8% and 94.5% were observed in reduction of aromatic and alpha-halo ketones, respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 33 publications
0
3
0
1
Order By: Relevance
“…On the other hand, 1,2,4- and 1,3,4-oxadiazoles have also been extensively studied in the past decade [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. A wide range of biologically active pharmacophores possess these five-membered heteroaromatic ring systems with remarkable biological properties including sphinosine kinase inhibitor [ 29 ], diacylglycerol acyltransferase 1 (DGAT-1) inhibitor [ 30 ], glycogen synthase kinase (GSK-3) inhibitor [ 31 ], sirtuin (SIRT) inhibitor [ 32 ] and methionine aminopeptidase inhibitor activities [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, 1,2,4- and 1,3,4-oxadiazoles have also been extensively studied in the past decade [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. A wide range of biologically active pharmacophores possess these five-membered heteroaromatic ring systems with remarkable biological properties including sphinosine kinase inhibitor [ 29 ], diacylglycerol acyltransferase 1 (DGAT-1) inhibitor [ 30 ], glycogen synthase kinase (GSK-3) inhibitor [ 31 ], sirtuin (SIRT) inhibitor [ 32 ] and methionine aminopeptidase inhibitor activities [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…40,42 The use of the phenyl analogue Ic seems to have advantages in the reduction of 1-(4-nitrophenyl)ethanone 1i, 12 while the derivatives Id-e are good catalysts for the preparation of the trifluoroalcohol 8c. Of all the bi-and tridentate catalysts prepared and tested, [16][17][18][19][20][21] catalyst IV appears to be the most efficient. Catalyst IV 16 performs especially well in the reduction of 2,2,2-trifluoro-1-phenylethanone 4c and 1-(3,5-dinitrophenyl)ethanone (95% ee, data not shown).…”
Section: Comparison Of Catalyst II With Other Prolinol Systemsmentioning
confidence: 99%
“…[13][14][15] Also, some C2 and C3 symmetric diphenylprolinol based systems have been evaluated in asymmetric borane reductions. [16][17][18][19][20][21] 0957-4166/$ -see front matter Ó 2011 Elsevier Ltd. All rights reserved. …”
Section: Introductionmentioning
confidence: 99%
“…Os métodos experimentais até a obtenção do composto (5) foram baseados na literatura. 107 assim como os de obtenção dos compostos (9), (10), (11) e (12). 42 Os ligantes finais terão a sua caracterização totalmente discutida na seção Resultados e Disscussão.…”
Section: Síntesesunclassified